Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) | PAR 20 303

Opportunity Information: Apply for PAR 20 303

The NIH funding opportunity "Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)" (PAR-20-303) supports short, exploratory research projects that look at how state and local tobacco prevention and control policies can reduce unequal patterns of tobacco use and secondhand smoke exposure across the United States. The core idea is to generate practical, policy-relevant evidence through either observational studies or intervention research, with an emphasis on innovative approaches that can be tested, evaluated, and potentially scaled. While the award mechanism is an R21, meaning it is meant for early-stage or high-impact exploratory work, the intent is still very applied: the research should help explain what policies work, for whom they work, under what conditions, and how they can close gaps between populations that have historically carried a heavier burden of tobacco-related harm.

A central theme of the FOA is health equity. NIH is specifically interested in projects that address disparities in tobacco use and secondhand smoke exposure that contribute to unequal rates of tobacco-related cancers and other health outcomes. In practice, this means the research should focus on populations and communities that experience disproportionate tobacco marketing, higher tobacco retailer density, lower access to cessation resources, weaker protections from secondhand smoke, or policy environments that do not provide the same level of health protection across neighborhoods. The long-term goal is to reduce disparities in tobacco-related cancers and, by extension, promote health equity across all populations.

The FOA is centered on state and local policy, so applicants are expected to study or test policy levers that operate at those levels rather than purely individual-level behavior change programs. This can include evaluating the impact of new or existing tobacco control laws, regulations, or enforcement strategies; examining how policies are adopted and implemented; identifying unintended consequences; or developing and assessing policy interventions designed to improve protections and reduce inequities. Since the announcement allows clinical trials but does not require them ("clinical trial optional"), projects may range from quasi-experimental evaluations of real-world policy changes to controlled intervention studies, as long as they align with NIH definitions and requirements.

NIH also flags health economics as an area where alignment with NIH mission priorities matters, encouraging applicants who plan economics-focused proposals to consult NIH guidance (NOT-OD-16-025). That note is essentially a reminder that economic analyses should be connected to health outcomes and NIH-relevant scientific questions, rather than being purely fiscal or market analyses. For applicants considering cost-effectiveness, taxation impacts, pricing policies, or other economic policy evaluations, the expectation is that the economic work strengthens the public health and equity focus of the project.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public housing authorities and Indian housing authorities; public and private institutions of higher education; federally recognized tribal governments; and tribal organizations that are not federally recognized. The FOA also allows nonprofits with and without 501(c)(3) status, as well as for-profit organizations (other than small businesses) and small businesses. It explicitly highlights additional eligible applicants such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), along with faith-based and community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. At the same time, it clearly excludes non-U.S. institutions and foreign organizations, and it does not allow foreign components of U.S. organizations as defined by the NIH Grants Policy Statement.

Administratively, this is a discretionary grant in the Education and Health activity category under CFDA 93.395, administered by the National Institutes of Health. The listed award ceiling is $200,000, reflecting the smaller, exploratory scope typical of R21 projects. The opportunity was created on 2020-09-04, and the original closing date shown in the source information is 2023-09-07. Overall, the opportunity is designed to help build the evidence base for equitable tobacco control by supporting timely, policy-focused research that can inform decisions at the state and local level and ultimately reduce tobacco-related cancer disparities.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395.
• This funding opportunity was created on 2020-09-04.
• Applicants must submit their applications by 2023-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $200,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 20 303

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: